Humoral immune response after Ad26.COV2.S vaccination in patients with multiple sclerosis treated with natalizumab.

Gudesblatt, Mark; Zarif, Myassar; Bumstead, Barbara; Buhse, Marijean; Kaczmarek, Olivia; Li, Hanyue; Sun, Zhaonan; Scott, Nicole; Mendoza, Jason P; Avila, Robin L

Gudesblatt, Mark; Zarif, Myassar; Bumstead, Barbara; Buhse, Marijean; Kaczmarek, Olivia; Li, Hanyue; Sun, Zhaonan; Scott, Nicole; Mendoza, Jason P; Avila, Robin L.

Affiliation

Gudesblatt M; NYU Langone South Shore Neurologic Associates, PC, Patchogue, NY, USA.
Zarif M; NYU Langone South Shore Neurologic Associates, PC, Patchogue, NY, USA.
Bumstead B; NYU Langone South Shore Neurologic Associates, PC, Patchogue, NY, USA.
Buhse M; NYU Langone South Shore Neurologic Associates, PC, Patchogue, NY, USA.
Kaczmarek O; NYU Langone South Shore Neurologic Associates, PC, Patchogue, NY, USA.
Li H; Biogen, Cambridge, MA, USA.
Sun Z; Biogen, Cambridge, MA, USA.
Scott N; Biogen, Cambridge, MA, USA.
Mendoza JP; Biogen, Cambridge, MA, USA.
Avila RL; Biogen, Cambridge, MA, USA.